Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 2,2212,240 of 20,252 grants

Active NON-SBIR/STTR RPGS
Regulation of Protein Synthesis in Leukemia Stem Cells
NATIONAL CANCER INSTITUTE Ut Southwestern Medical Center United States 2023 – 2028

Summary/Abstract Leukemia stem cells (LSCs) promote therapeutic resistance and poor clinical outcomes in acute myeloid leukemia (AML). Central to the function of LSCs is a capacity...

$4.75M
USD
Active RESEARCH CENTERS
2/2 Collaborative Union for Cancer Research, Education, and Disparities (CURED)
NATIONAL CANCER INSTITUTE Texas Southern University United States 2023 – 2027

CURED Overall Abstract Dan L Duncan Comprehensive Cancer Center (DLDCCC) at Baylor College of Medicine (BCM) and Texas Southern University (TSU) are jointly submitting a P20 applic...

$2.71M
USD
Active RESEARCH CENTERS
BCM/TSU P20 Collaborative Union for Cancer Research, Education and Disparities (CURED) Administrative Core (AC)
NATIONAL CANCER INSTITUTE Texas Southern University United States 2023 – 2027

ABSTRACT – CURED Administrative Core Administrative Core of the proposed BCM-TSU P20 CURED program will serve as a primary administrative unit that oversees the collaborative resea...

Active NON-SBIR/STTR RPGS
Intensive cholesterol-lowering intervention and anti-tumor immunity modeled in prostate cancer
NATIONAL CANCER INSTITUTE Cedars-Sinai Medical Center United States 2023 – 2028

PROJECT SUMMARY In epidemiologic studies, a strong association has been noted between cholesterol-lowering therapy with statins and lower risk of death from prostate cancer. Animal...

$6.92M
USD
Active RESEARCH CENTERS
1/2 Collaborative Union for Cancer Research, Education and Disparities (CURED)
NATIONAL CANCER INSTITUTE Baylor College of Medicine United States 2023 – 2027

CURED Overall Abstract Dan L Duncan Comprehensive Cancer Center (DLDCCC) at Baylor College of Medicine (BCM) and Texas Southern University (TSU) are jointly submitting a P20 applic...

$2.85M
USD
Active NON-SBIR/STTR RPGS
Developing and Testing a Culturally Tailored Mobile Health and Social MediaPhysical Activity Intervention Among Adolescent and Young Adult ChildhoodCancer Survivors
NATIONAL CANCER INSTITUTE Seattle Children'S Hospital United States 2023 – 2026

ABSTRACT Latinx childhood cancer survivors have an increased risk of cardiometabolic dysfunction. While physical activity (PA) is associated with lower risk of cancer recurrence, c...

$3.77M
USD
Completed SBIR-STTR RPGS
Next Generation Gene-Gun Delivered DNA and RNA Immunotherapeutic Vaccines for Melanoma.
NATIONAL CANCER INSTITUTE Orlance, Inc United States 2023 – 2025

PROJECT SUMMARY Orlance has developed a next-generation Gene Gun (MACH-1 GG) that efficiently delivers DNA and RNA into epidermal cells, leading to robust immune responses. Sequenc...

$2M
USD
Completed SBIR-STTR RPGS
Assigning mode of action to phenotypically discovered anticancer leads.
NATIONAL CANCER INSTITUTE Attagene, Inc United States 2023 – 2025

ABSTRACT. Assigning the mode of action to bioactive compounds is an essential step in drug discovery and a major challenge in chemical biology. This problem is particularly acute f...

$10M
USD
Active NON-SBIR/STTR RPGS
Assessing Benefits and Harms of Cannabis and Cannabinoid Use Among a Cohort of Cancer Patients Treated in Community Oncology Clinics
NATIONAL CANCER INSTITUTE Wake Forest University Health Sciences United States 2023 – 2028

SUMMARY Cancer patients suffer from a multitude of debilitating symptoms associated with cancer and cancer treatment, many of which are not relieved with prescription medications....

$6.19M
USD
Active NON-SBIR/STTR RPGS
Regulation of Protein Synthesis in Leukemia Stem Cells
NATIONAL CANCER INSTITUTE Ut Southwestern Medical Center United States 2023 – 2028

Summary/Abstract Leukemia stem cells (LSCs) promote therapeutic resistance and poor clinical outcomes in acute myeloid leukemia (AML). Central to the function of LSCs is a capacity...

$4.52M
USD
Active NON-SBIR/STTR RPGS
Intensive cholesterol-lowering intervention and anti-tumor immunity modeled in prostate cancer
NATIONAL CANCER INSTITUTE Cedars-Sinai Medical Center United States 2023 – 2028

PROJECT SUMMARY In epidemiologic studies, a strong association has been noted between cholesterol-lowering therapy with statins and lower risk of death from prostate cancer. Animal...

$6.57M
USD
Completed SBIR-STTR RPGS
Next Generation Gene-Gun Delivered DNA and RNA Immunotherapeutic Vaccines for Melanoma.
NATIONAL CANCER INSTITUTE Orlance, Inc United States 2023 – 2025

PROJECT SUMMARY Orlance has developed a next-generation Gene Gun (MACH-1 GG) that efficiently delivers DNA and RNA into epidermal cells, leading to robust immune responses. Sequenc...

$2M
USD
Active RESEARCH CENTERS
2/2 Collaborative Union for Cancer Research, Education, and Disparities (CURED)
NATIONAL CANCER INSTITUTE Texas Southern University United States 2023 – 2027

CURED Overall Abstract Dan L Duncan Comprehensive Cancer Center (DLDCCC) at Baylor College of Medicine (BCM) and Texas Southern University (TSU) are jointly submitting a P20 applic...

$2.86M
USD
Active RESEARCH CENTERS
BCM/TSU P20 Collaborative Union for Cancer Research, Education and Disparities (CURED) Administrative Core (AC)
NATIONAL CANCER INSTITUTE Texas Southern University United States 2023 – 2027

ABSTRACT – CURED Administrative Core Administrative Core of the proposed BCM-TSU P20 CURED program will serve as a primary administrative unit that oversees the collaborative resea...

Active NON-SBIR/STTR RPGS
Developing a Suite of Targeted Anticancer Drugs
NATIONAL CANCER INSTITUTE University of Illinois At Urbana-Champai... United States 2023 – 2030

Abstract The stunning clinical success of Gleevec (imatinib) two decades ago appeared to usher in a new era for cancer treatment, whereby a molecular defect in a patient’s tumor wa...

$7.61M
USD
Active NON-SBIR/STTR RPGS
A Prospective Cohort Study of Patients with Non-Small Cell Lung Cancer and Multiple Myeloma to Assess the Benefits and Harms Related to Cannabis Use During Treatment
NATIONAL CANCER INSTITUTE Beckman Research Institute/City of Hope United States 2023 – 2028

With the majority of Americans supporting legalization of medical cannabis, the number of patients asking their clinicians about medical cannabis has also significantly increased....

$6.22M
USD
Active NON-SBIR/STTR RPGS
Metabolic effects of cooper in renal cancer
NATIONAL CANCER INSTITUTE University of Cincinnati United States 2023 – 2028

Clear cell renal cell carcinoma (ccRCC) is a frequent and malignant renal cancer with a glycolytic phenotype due to the loss of VHL tumor suppressor and activation of HIF transcrip...

$5.78M
USD
Active NON-SBIR/STTR RPGS
Development, review, and conduct of Children's Oncology Group (COG) Clinical Trials
NATIONAL CANCER INSTITUTE Children'S Research Institute United States 2023 – 2028

Abstract Childhood cancer is the leading cause of disease-related death in children in the United States. The Children’s Oncology Group (COG), one of five clinical trials groups su...

$1.42M
USD
Completed TRAINING, INDIVIDUAL
Investigating tumor-mesothelial cell interactions during ovarian cancer metastasis
NATIONAL CANCER INSTITUTE Washington University United States 2023 – 2024

PROJECT SUMMARY Ovarian cancer is the leading cause of gynecological cancer-related deaths. The propensity for metastasis is a driving factor for the poor outcomes associated with...

$235.1K
USD
Active NON-SBIR/STTR RPGS
Development of blood-based methylation biomarkers for CRC risk prediction
NATIONAL CANCER INSTITUTE Temple University of the Commonwealth United States 2023 – 2028

Development of blood-based methylation biomarkers for CRC risk prediction Colorectal cancer (CRC) incidence and mortality rates are disproportionately higher in African Americans (...

$3.91M
USD